未登录

R

Roberta Ottria

university of milan

H指数:17

被引数:944

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut Microbiota-Derived Short-Chain Fatty Acids in Inflammatory Bowel Disease: Mechanistic Insights into Gut Inflammation, Barrier Function, and Therapeutic Potential

International Journal of Molecular Sciences

IF4.9

2026-01-230

OAAI

Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development

IF4.6

2025-04-030

OAAI

Tracing Zinc's Role in Preterm Infants' Health: A Narrative Review

追踪锌在早产儿健康中的作用: 叙述性综述

ADVANCES IN NUTRITION

IF9.2

2024-12-011

OAAI

Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2024-11-012

OAAI

Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases

IF4.2

2024-08-020

OAAI

Placental Bioenergetics and Antioxidant Homeostasis in Maternal Obesity and Gestational Diabetes

IF6.6

2024-07-181

OAAI

Lipids and lipid signaling molecules in human milk and infant formula, a chemical characterization of relevant biochemical components

JOURNAL OF NUTRITIONAL BIOCHEMISTRY

IF4.9

2024-04-011

OAAI

2-Arachidonoylglycerol Synthesis: Facile and Handy Enzymatic Method That Allows to Avoid Isomerization

IF4.6

2022-08-155

OAAI

Clarifying the Use of Benzylidene Protecting Group for D-(+)-Ribono-1,4-Lactone, an Essential Building Block in the Synthesis of C-Nucleosides

IF4.6

2021-10-263

OAAI

Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2+murine breast cancer model

SCIENTIFIC REPORTS

IF3.9

2020-07-1015

OAAI

Cardiosafe nano-formulation of doxorubicin allows coadministration with trastuzumab in neoadjuvant setting improving antitumor efficacy and preventing trastuzumab-mediated cardiotoxicity in HER2+murine model of breast cancer

ANNALS OF ONCOLOGY

IF65.4

2020-05-010

OAAI

Simple Synthesis of 17-β-O-hemisuccinate of Stanozolol for Immunoanalytical Methods

IF4.6

2020-04-262

OAAI

Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines

IF5.5

2019-08-0220

OAAI

Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe

IF4.6

2019-06-1512

OAAI

Quantitative Characterization of Olaparib in Nanodelivery System and Target Cell Compartments by LC-MS/MS (vol 24, pg 989, 2019)

IF4.6

2019-05-070

OAAI

Quantitative Characterization of Olaparib in Nanodelivery System and Target Cell Compartments by LC-MS/MS

IF4.6

2019-03-1111

OAAI

Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2018-05-0117

PREAI

H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer

SCIENTIFIC REPORTS

IF3.9

2017-08-0862

OAAI

Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2017-02-0123

PRE

Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease

生物活性脂肪酸酰胺衍生物对斑马鱼骨代谢及疾病模型的影响

PHARMACOLOGICAL RESEARCH

IF10.5

2016-02-0129

PREAI